https://www.selleckchem.com/products/jph203.html
To determine the ability of a EULAR/ACR SLE criteria score ≥20 to predict damage accrual and mortality. Inception SLE patients from the Toronto Lupus Clinic recruited in the first 12 months after diagnosis were included. A EULAR/ACR criteria score was calculated based on the baseline clinical and laboratory information. A EULAR/ACR score of 20 was used as a threshold to compare outcomes between groups (EULAR/ACR score 20vs ≥2, based on receiver operating characteristic analysis. 867 SLE patients were included. The group of patients